180 related articles for article (PubMed ID: 38118408)
21. Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome.
Romacho T; Valencia I; Ramos-González M; Vallejo S; López-Esteban M; Lorenzo O; Cannata P; Romero A; San Hipólito-Luengo A; Gómez-Cerezo JF; Peiró C; Sánchez-Ferrer CF
Sci Rep; 2020 Mar; 10(1):5386. PubMed ID: 32214150
[TBL] [Abstract][Full Text] [Related]
22. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
[TBL] [Abstract][Full Text] [Related]
23. EV71 3D Protein Binds with NLRP3 and Enhances the Assembly of Inflammasome Complex.
Wang W; Xiao F; Wan P; Pan P; Zhang Y; Liu F; Wu K; Liu Y; Wu J
PLoS Pathog; 2017 Jan; 13(1):e1006123. PubMed ID: 28060938
[TBL] [Abstract][Full Text] [Related]
24. Herpes simplex virus type 1 inflammasome activation in proinflammatory human macrophages is dependent on NLRP3, ASC, and caspase-1.
Karaba AH; Figueroa A; Massaccesi G; Botto S; DeFilippis VR; Cox AL
PLoS One; 2020; 15(2):e0229570. PubMed ID: 32101570
[TBL] [Abstract][Full Text] [Related]
25. NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia
Zhong C; Wang R; Hua M; Zhang C; Han F; Xu M; Yang X; Li G; Hu X; Sun T; Ji C; Ma D
Front Immunol; 2021; 12():661939. PubMed ID: 34211462
[TBL] [Abstract][Full Text] [Related]
26. 1'-Acetoxychavicol acetate inhibits NLRP3-dependent inflammasome activation via mitochondrial ROS suppression.
Sok SPM; Ori D; Wada A; Okude H; Kawasaki T; Momota M; Nagoor NH; Kawai T
Int Immunol; 2021 Jun; 33(7):373-386. PubMed ID: 33830232
[TBL] [Abstract][Full Text] [Related]
27. The mechanism of NLRP3 inflammasome initiation: Trimerization but not dimerization of the NLRP3 pyrin domain induces robust activation of IL-1β.
Sušjan P; Roškar S; Hafner-Bratkovič I
Biochem Biophys Res Commun; 2017 Feb; 483(2):823-828. PubMed ID: 28065854
[TBL] [Abstract][Full Text] [Related]
28. Activation of the NLRP3 inflammasome in microglia: the role of ceramide.
Scheiblich H; Schlütter A; Golenbock DT; Latz E; Martinez-Martinez P; Heneka MT
J Neurochem; 2017 Dec; 143(5):534-550. PubMed ID: 28940479
[TBL] [Abstract][Full Text] [Related]
29. Activation of NLRP3 inflammasome in macrophages by mycoplasmal lipoproteins and lipopeptides.
Saeki A; Sugiyama M; Hasebe A; Suzuki T; Shibata K
Mol Oral Microbiol; 2018 Aug; 33(4):300-311. PubMed ID: 29682880
[TBL] [Abstract][Full Text] [Related]
30. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.
Luo B; Li B; Wang W; Liu X; Xia Y; Zhang C; Zhang M; Zhang Y; An F
PLoS One; 2014; 9(8):e104771. PubMed ID: 25136835
[TBL] [Abstract][Full Text] [Related]
31. Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell.
Yao M; Fan X; Yuan B; Takagi N; Liu S; Han X; Ren J; Liu J
BMC Complement Altern Med; 2019 Aug; 19(1):216. PubMed ID: 31412862
[TBL] [Abstract][Full Text] [Related]
32. Fluorofenidone attenuates interleukin-1β production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction.
Zheng L; Zhang J; Yuan X; Tang J; Qiu S; Peng Z; Yuan Q; Xie Y; Mei W; Tang Y; Meng J; Hu G; Tao L
Nephrology (Carlton); 2018 Jun; 23(6):573-584. PubMed ID: 28437591
[TBL] [Abstract][Full Text] [Related]
33. ["Trichosanthis Fructus-Allii Macrostemonis Bulbus" combination inhibits NLRP3 inflammasome activation and reduces inflammatory response in RAW264.7 macrophage by inducing autophagy].
Bao YL; Cao Y; Wu HF
Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2820-2828. PubMed ID: 37282942
[TBL] [Abstract][Full Text] [Related]
34. Monosodium Urate Crystals Activate the Inflammasome in Primary Progressive Multiple Sclerosis.
Piancone F; Saresella M; Marventano I; La Rosa F; Santangelo MA; Caputo D; Mendozzi L; Rovaris M; Clerici M
Front Immunol; 2018; 9():983. PubMed ID: 29780394
[TBL] [Abstract][Full Text] [Related]
35. Lytic cell death induced by melittin bypasses pyroptosis but induces NLRP3 inflammasome activation and IL-1β release.
Martín-Sánchez F; Martínez-García JJ; Muñoz-García M; Martínez-Villanueva M; Noguera-Velasco JA; Andreu D; Rivas L; Pelegrín P
Cell Death Dis; 2017 Aug; 8(8):e2984. PubMed ID: 28796264
[TBL] [Abstract][Full Text] [Related]
36. SUMO1 SUMOylates and SENP3 deSUMOylates NLRP3 to orchestrate the inflammasome activation.
Shao L; Liu Y; Wang W; Li A; Wan P; Liu W; Shereen MA; Liu F; Zhang W; Tan Q; Wu K; Liu Y; Wu J
FASEB J; 2020 Jan; 34(1):1497-1515. PubMed ID: 31914638
[TBL] [Abstract][Full Text] [Related]
37. Carbon monoxide releasing molecule-3 improves myocardial function in mice with sepsis by inhibiting NLRP3 inflammasome activation in cardiac fibroblasts.
Zhang W; Tao A; Lan T; Cepinskas G; Kao R; Martin CM; Rui T
Basic Res Cardiol; 2017 Mar; 112(2):16. PubMed ID: 28168403
[TBL] [Abstract][Full Text] [Related]
38. NLRP3 inflammasome may regulate inflammatory response of human periodontal ligament fibroblasts in an apoptosis-associated speck-like protein containing a CARD (ASC)-dependent manner.
Lu WL; Song DZ; Yue JL; Wang TT; Zhou XD; Zhang P; Zhang L; Huang DM
Int Endod J; 2017 Oct; 50(10):967-975. PubMed ID: 27864974
[TBL] [Abstract][Full Text] [Related]
39. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
Marchetti C; Swartzwelter B; Gamboni F; Neff CP; Richter K; Azam T; Carta S; Tengesdal I; Nemkov T; D'Alessandro A; Henry C; Jones GS; Goodrich SA; St Laurent JP; Jones TM; Scribner CL; Barrow RB; Altman RD; Skouras DB; Gattorno M; Grau V; Janciauskiene S; Rubartelli A; Joosten LAB; Dinarello CA
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1530-E1539. PubMed ID: 29378952
[TBL] [Abstract][Full Text] [Related]
40. The RNA- and TRIM25-Binding Domains of Influenza Virus NS1 Protein Are Essential for Suppression of NLRP3 Inflammasome-Mediated Interleukin-1β Secretion.
Moriyama M; Chen IY; Kawaguchi A; Koshiba T; Nagata K; Takeyama H; Hasegawa H; Ichinohe T
J Virol; 2016 Apr; 90(8):4105-4114. PubMed ID: 26865721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
